Agios Pharmaceuticals
AGIO
#5104
Rank
A$2.53 B
Marketcap
A$42.30
Share price
-1.95%
Change (1 day)
22.89%
Change (1 year)

EPS for Agios Pharmaceuticals (AGIO)

EPS in 2026 (TTM): A-$9.15

According to Agios Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$9.38. In 2021 the company made an earnings per share (EPS) of A$33.36 an increase over its 2020 EPS that were of A-$7.11.

EPS history for Agios Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$9.15
2021A$33.36-569.2%
2020A-$7.11-31%
2019A-$10.3113.93%
2018A-$9.05-10.53%
2017A-$10.1133.47%
2016A-$7.5861.34%
2015A-$4.7098.1%
2014A-$2.37-4.34%
2013A-$2.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.07-111.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.34-594.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.32-146.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
A-$2.36-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$5.19-155.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.14-98.56%๐Ÿ‡บ๐Ÿ‡ธ USA